Private Equity

A three-year private equity partnership transforms a family utility firm, culminating in a $276M sale to MasTec and signaling big moves in U.S. water infrastructure.

Churchill Asset Management's top industry award reveals a surging demand for flexible junior capital as private equity navigates a complex market.

The industry's largest independent support provider modernizes its brand to reflect a strategic shift into a full-lifecycle ecosystem for aircraft owners.

MARSOC veterans secure $32M for Smack Technologies, an AI lab building a 'Decision Dominance' platform designed to reshape U.S. military strategy.

As SAB Biotherapeutics prepares for key investor talks, a closer look reveals its novel T1D therapy and the unique bovine tech aiming to change treatment.

Specialized Packaging Group's new 75,000-sq-ft Austin plant brings advanced manufacturing and sustainable solutions to the region's booming industries.

Snack giant Our Home unveils a strategic pivot at Expo West, doubling down on protein and avocado oil to capture the modern, health-conscious consumer.

A new partnership highlights how specialized tech is becoming essential for navigating complex IRA tax rules, de-risking billions in renewable energy projects.

Colombian law firm Contexto Legal appoints Federico Escobar as Managing Partner, signaling a strategic pivot from its founder's legacy to a new era of tech and global growth.

DRI Healthcare's strategic C$109M debt swap lowers interest costs, extends maturity, and signals strong investor confidence to fuel its acquisition pipeline.

Over 200 Wasilla school bus drivers are on strike, disrupting transport for 18,000 students amid a bitter dispute over wages, safety, and alleged unfair labor practices.

With a new unified command under mining veteran Mark Wall, American Rare Earths aims to accelerate its massive Halleck Creek project and secure the U.S. supply chain.

Reinsurance giant RGA hires Jayson Bronchetti, a top CIO known for managing $300B+ portfolios, signaling a new chapter for its investment engine.

Lantheus gains FDA tentative approval for a LUTATHERA rival, signaling new hope for rare cancer patients and a legal battle with Novartis over market access.

WNC CEO Will Cooper, Jr. is the new chairman of BUILD-PAC. Can his deep affordable housing focus reshape federal policy in a critical election year?

After a major turnaround, Genetix Biotherapeutics announces its first profitable quarter and plans to double production of its high-stakes gene therapies.

As Western Canada's housing crisis deepens, Ikigai Impact hires a 'Housing First' expert to lead its expansion and redefine affordable housing investment.

Ramaco Resources' CEO just exercised long-held options, signaling deep confidence as the company navigates a weak coal market and pivots to critical minerals.

Regulatory delays in China scuttled Pulmatrix's merger with Cullgen, forcing the biotech to urgently seek new partners for its promising drug pipeline.

With its sixth deal of 2026, WhiteHawk expands its footprint in the Haynesville Shale, tying its fortunes to the booming but controversial U.S. LNG market.